IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.
Frequently asked questions
What sector does IRadimed Corporation (IRMD) operate in?
IRadimed Corporation belongs to the Healthcare sector and operates in the Medical Devices industry.
What is IRadimed Corporation (IRMD) current stock price?
As of the latest data, IRadimed Corporation stock price is $87.87, with a previous close of $87.18. IRadimed Corporation gained $0.69 in the last trading session, representing a 0.79% increase.
What is IRadimed Corporation (IRMD) current market capitalization?
IRadimed Corporation market cap is approximately 1.12 billion.
What is IRadimed Corporation (IRMD) Earnings Per Share (EPS)?
The trailing EPS is $1.81, and the forward EPS is $2.41.
What is IRadimed Corporation (IRMD) Price-to-Earnings (P/E) ratio?
IRadimed Corporation current P/E ratio is 48.55, with a forward P/E of 36.46.
What is IRadimed Corporation (IRMD) EBITDA?
IRadimed Corporation EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 6.80 million.
Does IRadimed Corporation (IRMD) pay dividends?
Yes. IRadimed Corporation pays quarterly dividends with an annualized yield of 0.91% and an estimated annual payout of $0.80 per share.
When is the next ex-dividend date for IRadimed Corporation (IRMD)?
The next ex-dividend date is scheduled for August 14, 2026.
How did IRadimed Corporation (IRMD) perform in its most recent earnings report?
In the last report (June 30, 2026), IRadimed Corporation posted an EPS surprise of -2.38% and a revenue surprise of 0.57%.
What is IRadimed Corporation (IRMD) beta (volatility) score?
IRadimed Corporation has a beta of 0.910, meaning its volatility is roughly in line with the market.
